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ABSTRACT 
Obesity has been increasing in epidemic proportions, with a disproportionately higher 
increase in morbid or class III obesity, and obesity adversely impacts cardiovascular (CV) 
hemodynamics, structure and function, as well as increases the prevalence of most CV diseases. 
Progressive declines in physical activity over 5 decades have occurred and have primarily caused 
the obesity epidemic. Despite the potential adverse impact of overweightness and obesity, recent 
epidemiological data have demonstrated an association of mild obesity and, particularly, 
overweightness on improved survival. We review in detail the obesity paradox in CV diseases 
where overweight and at least mildly obese with most CV diseases seem to have a better 
prognosis than do their leaner counterparts. The implications of cardiorespiratory fitness with 
prognosis are discussed, along with the joint impact of fitness and adiposity on the obesity 
paradox. Finally, in light of the obesity paradox, the potential value of purposeful weight loss 
and increased physical activity to impact levels of fitness are reviewed.  
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Abbreviations 
BF  =  body fat 
BMI  =  body mass index 
CHD  =  coronary heart disease 
CV  =  cardiovascular 
HF  = heart failure 
LV  = left ventricle 
LVH  =  left ventricular hypertrophy 
MET  =  metabolic equivalent 
VO2  =  oxygen consumption 
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Obesity has been increasing in epidemic proportions in both adults and children over 
many decades, and recently the proportion of the population with more severe, or morbid, 
obesity has increased to a greater extent than has overweight and mild obesity.1-3 Currently, 
nearly 70% of adults are classified as either overweight or obese as compared with fewer than 
40% just forty years ago.3 One can argue about the impact of overweightness and mild obesity 
on overall prognosis particularly without accounting for levels of cardiorespiratory fitness 
(fitness). Nevertheless, very recent high profile data have suggested obesity may account for 
nearly 20% of overall mortality.4 
There are numerous adverse effects of overweightness and obesity on general and 
cardiovascular (CV) health.3 Clearly, obesity worsens most of the major CV risk factors, 
including plasma lipids, blood pressure, glucose, inflammation, and places a "heavy" burden on 
the heart, negatively impacting ventricular structure and systolic and diastolic ventricular 
function.3,5,6 Not surprisingly, obesity is associated with the prevalence of most CV diseases, 
including hypertension, coronary heart disease (CHD), heart failure (HF), and atrial fibrillation 
(AF).3,5 Nevertheless, substantial data, mostly published during the last decade, have 
demonstrated an "obesity paradox", where obese patients generally have a better short-and long-
term prognosis then do their leaner counterparts with the same CV diseases.3,5  
This state of the art briefly reviews the pathophysiology/hemodynamics of obesity, 
discusses possible causes of the obesity epidemic, and reviews the changing landscape of obesity 
on survival in the general population and in those with CV diseases, including HTN, CHD, HF, 
and AF. Additionally, we discuss the impact of severe or morbid obesity on prognosis, especially 
in light of the obesity paradox noted at least in overweight and mildly obese patients with CV 
diseases. We also discuss the role of cardiorespiratory fitness (fitness) compared with fatness, 
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and implications of fitness in the obesity paradox. Finally, we briefly review the impact of 
purposeful weight reduction on prognosis, especially considering the obesity paradox. 
CV Pathophysiology/Hemodynamics 
Overweightness and obesity have many adverse effects on hemodynamics and CV 
structure and function (Figure 1, Table 1)5 which have been reviewed in detail elsewhere.3,5 
Obesity certainly increases total blood volume, stroke volume and cardiac output, so typically 
systemic vascular resistance in obesity is reduced for any given level of BP. Although most of 
the increases in cardiac output in obesity are due to high stroke volume (as heart rate is typically 
not increased), occasionally, heart rate may be slightly increased due to increased activation of 
the sympathetic nervous system. The Frank-Starling curve in obesity is often shifted to the left 
due to increases in filling pressure and volume, which increases CV work, also leading to left 
ventricular (LV) changes with dilatation and LV hypertrophy (LVH). Additionally, obesity can 
leads to enlargement of the left atrium, both from the increased circulating blood volume but also 
due to alterations in LV diastolic filling.5,7 From multiple mechanisms, obesity has adverse 
effects on both systolic and, especially, diastolic ventricular function.8  
Etiologies of Obesity and Energy Balance 
During recent years, the origins of the obesity epidemic have been in considerable 
dispute.9,10 Regardless of this debate, it is widely accepted that increments in body weight and 
overall adiposity, at the most fundamental level, are the result of chronic positive energy balance 
(that is, energy expenditure < energy intake).11,12 There has been a number of studies suggesting 
that energy or food intake is largely, if not completely, responsible for the obesity epidemic, 
essentially blaming much of the obesity epidemic in Westernized World on poor dietary 
choices.13-15 One of the arguments to support this theory is that time spent in leisure-time 
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physical activity has remained essentially unchanged in recent decades, thus leading to the 
conclusion that obesity is solely due to excessive energy or caloric intake.11 However, leisure-
time physical activity represents a relatively small portion of total time per week, which is much 
more impacted by occupation-related activity and household management energy expenditure.  
Recently, we have demonstrated very marked declines in occupation-related physical 
activity during the last five decades (Figure 2),11 with similar declines in household management 
energy expenditure in women during this same time (Figure 3).12,16 In fact, the typical female 
now has an energy expenditure that is over 1800 calories/week less than that present five decades 
ago.12 Considering the fact that generally 100 calories are burned for every mile traveled by foot, 
the typical female would have to walk or run over 18 miles/week to make up for this loss of 
household management energy expenditure. This suggests that reductions in occupation-related 
activity and energy expenditure, similar to household management energy expenditure in 
women, largely explain the marked increased prevalence in obesity noted during recent decades 
(Figure 4).11  
Importantly, because voluntary physical activity (e.g., housework, exercise) is the only 
major modifiable component of total daily energy expenditure, these significant reductions are 
independent of the relatively non-modifiable components of total daily energy expenditure such 
as resting metabolic rate,17   thermic effect of food,18 and non-exercise activity thermogenesis 
.
19,20
 
The Changing Landscape of Obesity 
Recently, scientists have debated the impact of overweightness and obesity on overall 
chronic disease, including all-cause mortality.21 In fact, it has been recently argued that obesity is 
accounting for almost one in five deaths worldwide.4 On the other hand, Flegal and colleagues21 
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have performed a large meta-analysis of 97 studies in nearly 2.9 million people. They 
demonstrated that obesity, defined by standard body mass index (BMI) criteria (BMI≥30kg/m2), 
when considering all grades, was associated with a significantly increased risk of mortality 
compared with normal BMI (BMI=18.5-25 kg/m2). However, the optimal survival occurred at 
the overweight BMI (25-30 kg/m2), who had a significantly 6% lower mortality than did the 
normal BMI cohort. Additionally, the mildly obese or Class I obese (BMI 30-35 kg/m2), had a 
5% lower mortality than did the normal BMI group, although this was not did not reach 
statistical significance. The adverse effects of higher BMI on mortality are particularly noted in 
younger cohorts, whereas higher BMI appears to be more protective in older cohorts.22 
Nevertheless, as mentioned previously, the prevalence of more extreme degrees of obesity seem 
to be increasing more so than is overweightness and mild obesity.1,2 In the Flegal meta-
analysis,21 the contribution of Class II obesity (BMI 35-40 kg/m2) and Class III obesity (BMI ≥ 
40 kg/m2) exists and appears particularly ominous, especially considering the fact that Class III 
or "morbid" obesity has been markedly increasing, now approaching 3 % prevalence in the US.1-
3
 Clearly, efforts to prevent and reverse these severe degrees of obesity are needed, whereas the 
data to support intervention in overweight and mild obesity is less so.  
Obesity Paradox 
Despite the adverse impact of overweightness and obesity on most of the CV risk factors 
as well as increasing the prevalence of most CV diseases, numerous studies during the past 
decade demonstrate a clear obesity paradox, where overweight and obese with CV diseases have 
a better prognosis than do their leaner counterparts.3 The mechanisms for this paradox are 
difficult to reconcile, but several potential mechanisms are listed in Table 2. Additionally, it has 
been argued that BMI, the typical method used to assess obesity, has a poor diagnostic 
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performance to identify obesity in the general population and also in cohorts with CHD,23-26 
which may explain some, although not all, of the paradoxes listed in this review. Therefore, we 
also briefly review the impact of other assessments of obesity, including waist circumference and 
body fat (BF).  
Hypertension. Obese patients have a higher prevalence of hypertension compared with 
lean subjects, and obesity adversely impacts CHD risk factors and leads to increased prevalence 
of LVH, independent of arterial pressure. However, several studies demonstrate an obesity 
paradox in hypertensive subjects. The largest of such studies is from Uretsky et al27 who 
investigated the effects of obesity on outcomes in 22,576 patients with treated hypertension and 
with known CHD. Despite an overall worse control of blood pressure during a 2-year follow-up, 
all-cause mortality was 30% lower in overweight and obese hypertensive patients compared with 
their lean counterparts. Other studies have either demonstrated the same finding or demonstrated 
a U-shaped relationship between BMI and all-cause, CV, and non-CV mortality, being that 
excess mortality was noted at both extremes of BMI.3 Certainly, overweight and morbidly obese 
hypertensive patients seem to have a better prognosis than do their leaner counterparts.  
CHD. Obesity plays a major role in adversely affecting CHD risk factors and increasing 
the prevalence of CHD,3 although some studies indicate that CHD may not be increased in 
"metabolically healthy" obesity.28-31 Nevertheless, as with hypertension, many studies using 
various measures of adiposity, including BMI,32-41 % body fat (BF),33-35 and some even with 
central obesity or waist circumference (WC)34 have demonstrated an obesity paradox in CHD. 
Romero-Corral and colleagues32 performed a meta-analysis of 40 cohort studies in over 250,000 
patients with CHD and reported that overweight and obese CHD patients have a lower risk of 
total and CV mortality compared with underweight and normal-weight CHD patients. However, 
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they demonstrated that in patients with Class II obesity (BMI 35-40 kg/m2), there was an excess 
risk of CV mortality without any increase in total mortality. Recently, some studies have 
demonstrated an increased risk in CHD patients with normal weight obesity but with increased 
central obesity or waist circumference,31,36,37 whereas others have only demonstrated this finding 
in those with low fitness (discussed below).34  
Several recent studies have raised the possibility that the association with lower adiposity 
and worse outcomes in CHD may represent as much as a "lean paradox" as an obesity 
paradox.33,35,38,39 We have demonstrated this obesity paradox with low BF (defined as < 25% in 
men and < 35% in women) and low BMI,33,40 and both low BF and low BMI are independent 
predictors of worse outcomes. However, in a study of 581 patients with CHD, we demonstrated 
that only those with low BMI (< 25 kg/m2) and low BF had a high mortality compared with the 
other groups.33 Most recently, we demonstrated that both low BF and low lean mass (or non-fat 
mass) is associated with the worst survival, patients with both high lean mass and BF had the 
best survival, whereas intermediate survival rates were noted in the other groups (Figure 5).35 
Other studies demonstrate that this may represent more of an "overweight paradox", where 
overweight CHD patients do particularly well compared with lean.38,39  
Therefore, in CHD, it appears that there is a strong obesity paradox, particularly with 
BMI, but also with BF and central obesity, with the best prognosis noted in overweight CHD 
patients, as opposed to those with more severe obesity.41  
 HF. Since obesity causes marked abnormalities in LV structure and function,3,5 the 
increase in the prevalence of HF with obesity is not surprising. Kenchaiah and colleagues42 
studied 5,881 Framingham's Heart Study participants and demonstrated a 5% increase in HF 
prevalence in men and a 7% increase in women for every 1 kg/m2 increase in BMI, with the risk 
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of HF increasing across the entire spectrum of BMI. However, in a study of 550 subjects without 
diabetes, increased BMI was not associated with increased risks of HF, whereas metabolic 
syndrome increased the risk of HF by 2.5-fold.43 In this study, in contrast to normal weight 
patients with metabolic syndrome, metabolically healthy obese subjects had a decreased HF risk 
in a 6-year follow-up. However, a recent study from Norway demonstrated that in contrast to 
CHD, metabolically healthy obese still had an increased risk of HF.29 Alpert and colleagues44 
demonstrated a very strong relationship between morbid obesity and HF prevalence. 
The obesity paradox in HF has recently been reviewed in detail.5 In a meta-analysis of 
observational HF studies (N=28,209), Oreopoulous et al45 demonstrated that compared with 
patients with normal BMI, overweight and obese HF patients had reductions in CV (-19% and -
40%, respectively) and total mortality (-16% and -33% respectively) during an average 2.7 year 
follow-up. The obesity paradox in HF has been demonstrated with BMI, % BF, and with waist 
circumference or central obesity.5,46-48 
Atrial Fibrillation. As with obesity, the prevalence of atrial fibrillation has been 
increasing and is expected to increase by 2.5-fold during the next 30 years.3 The increase in atrial 
fibrillation may be partly due to the obesity epidemic, with its adverse hemodynamic effects and 
the impact on LV and left atrial structure and function.3,7 In a meta-analysis of 16 studies of over 
120,000 patients, Wanahita et al49 demonstrate that obese had a 50% increased risk of developing 
AF. However, as in HTN, CHD, and HF, overweight and obese with atrial fibrillation have a 
considerably better prognosis than do those patients with normal levels of BMI.3  
Impact of Morbid Obesity 
The prevalence of morbid or Class III obesity (BMI ≥ 40 kg/m2) has been dramatically 
increasing, and is now present in close to 3% of the US population.1,2 Although an obesity 
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paradox exists, recent evidence suggests that this does not typically apply to more morbid 
obesity, where prognosis is adversely impacted in acute CHD,50,51 CHD patients undergoing 
revascularization,52,53 including percutaneous intervention and coronary artery bypass grafting, 
as well as in patients with HF.54,55 This level of severe obesity is a major risk factor for 
development of CV diseases and is associated with poor prognosis when CV diseases become 
manifest. Therefore, efforts to prevent and treat morbid obesity are urgently needed.  
Impact of Cardiorespiratory Fitness  
 Fitness versus Fatness. Body fatness and fitness are strong predictors of CV disease risk 
factors as well as CV morbidity and mortality.3,56-58 The relative and combined contributions of 
fitness and fatness to health are controversial, but substantial evidence suggest that fitness 
remains very predictive and largely negates the adverse effects of body fatness, as well as other 
traditional CV risk factors, including overweightness/obesity, metabolic syndrome/type II 
diabetes mellitus, and hypertension.59-64 In most of these CV disorders, patients with high fitness 
have lower mortality than do patients without these disorders but with low levels of fitness. In a 
recent meta-analysis of 33 studies of over 100,000 participants, Kodama et al58 demonstrated that 
for every one metabolic equivalent (MET) increase in fitness, all-cause mortality and CHD/CV 
events are reduced by 13% and 15%, respectively. In 66,371 subjects without prior CV disease 
from the Cooper Center Longitudinal Study, a single measure of fitness significantly improved 
classification of both 10-year and 25-year risks for CV mortality when added to traditional CV 
risk factors.65 In a study of 3,148 healthy adults, changes over time in both adiposity (BMI and % 
BF) and fitness predicted the development of hypertension, metabolic syndrome, and 
hypercholesterolemia, but the impact of fitness appears somewhat better than did adiposity for 
future risk of these CV disorders.66 In addition, a one MET increase in fitness on two maximal 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
11 
 
exercise stress tests separated by an average of 6.3 years in 14,345 men was associated with 
reductions in all-cause and CV mortality of 15% and 19%, respectively; BMI change was not 
associated with all-cause and CV mortality after adjusting for possible confounders and changes 
in fitness.67 The constellation of these data suggest that although ideal prevention of age-
associated loss in fitness and increase in adiposity both may be useful, maintaining or improving 
fitness is more important than preventing increased adiposity with regards to long-term health 
outcomes. 
Obesity Paradox and Fitness. Several studies have suggested that fitness markedly 
alters the relationship between adiposity and prognosis in both CHD and HF.34,68-70 In a recent 
study of nearly 10,000 patients with CHD, only those in the bottom 33 percentile for age- and 
gender- levels of fitness demonstrated an obesity paradox, which was present by BMI, %BF, and 
even by waist circumference or central obesity (Figure 6).34 On the other hand, CHD patients 
without low fitness had a good prognosis regardless of their level of adiposity, so no obesity 
paradox was apparent, which has been described elsewhere.71 We recently demonstrated the 
same finding in 2,066 patients with systolic HF; in fact, HF patients with peak oxygen 
consumption (peak VO2) < 14cc/kg/min had a poor prognosis, and a strong obesity paradox was 
present, with obese (BMI > 30 kg/m2) having a better prognosis, lean (BMI 18.5– 25 kg/m2) 
having a particularly poor prognosis, and overweight (BMI 25-30 kg/m2) having an intermediate 
prognosis. On the other hand, HF patients with relatively preserved fitness (peak VO2 > 14 
cc/kg/min) had a good overall prognosis regardless of BMI, and again no obesity paradox was 
apparent (Figure 7).69 A recent study by Uretsky et al72 however, of more than 5,000 patients 
with normal nuclear perfusion stress tests, demonstrated that an obesity paradox was maintained 
regardless of the level of fitness. Nevertheless, those with relatively preserved fitness (≥ 6 
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estimated METs) had an extremely low mortality of less than 1% per year, although the normal 
BMI group had a higher mortality (1.4%/year) compared with the overweight and obese 
(0.9%/year and 0.6%/year, respectively).72,73 None of these studies, however, have adequately 
accessed the impact of fitness on prognosis of patients with severe obesity, particularly with 
Class II and III obesity (BMI 35-40 and > 40 kg/m2, respectively). It is noteworthy, that in this 
latter group of patients, assessing levels of fitness can be challenging.  
Role of Purposeful Weight Reduction  
The role of purposeful weight reduction, except in the morbidly obese patient, where 
obesity is particularly detrimental to health outcomes, continues to be controversial.3,5,74,75 Some 
long-term studies have suggested that weight loss may be associated with increased mortality,3,76 
and coupled with the obesity paradox discussed above, it has been suggested that purposeful 
weight loss can be detrimental. However, clearly lifestyle interventions with diet and exercise 
training and at least mild weight reduction have markedly reduced the prevalence of metabolic 
syndrome and type II diabetes mellitus,77-79 although a recent large study in diabetes did not 
demonstrate survival benefits from small amounts of weight loss in diabetic subjects.80 In a CHD 
study of 530 patients which demonstrated an obesity paradox, overweight and obese who were 
successful with purposeful weight reduction had a trend of lower mortality.40 In a study of 1,500 
CHD patients, intentional weight loss produced a lower incidence of CHD events over 4-year 
follow-up.81 A small study of 377 CHD patients showed the benefits of weight loss on major CV 
events even in patients with BMI < 25 kg/m2.82 
In hypertension, purposeful weight loss has resulted in marked improvements in arterial 
pressure and LV geometry.83 In HF, weight loss, especially with bariatric surgery, has improved 
LV geometry, systolic and diastolic function, and clinical symptoms.5 Currently, many severely 
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obese patients are being referred for bariatric surgery. Although 30-day mortality may be higher 
than ideal due to surgeon inexperience,84 most studies in severely obese and diabetic patients are 
showing improvements in short- and long-term prognosis.3,85-89 
Although better large scale weight loss intervention trials are needed, the constellation of 
data still supports purposeful weight reduction in patients with CV diseases, especially in the 
more severe obesity (probably BMI > 35 kg/m2 and especially BMI > 40 kg/m2). Considering the 
importance of fitness to improve prognosis in almost every patient group studied, including 
overweight and obese patients, as well as the clear evidence that improvements in fitness are 
associated with reductions in mortality in both CHD33,90,91 and HF,69,92 incorporating exercise 
training and efforts to improve fitness into weight loss programs appears to be particularly 
beneficial.93,94  
Conclusion 
Although obesity adversely impacts CV risk factors and LV structure and function and is 
associated with increased risk of most CV diseases, an obesity paradox exists showing that 
overweight and obese with CV diseases have a better prognosis than do their leaner counterparts. 
This obesity paradox seems largely apparent in patients with low fitness, whereas those with 
better fitness have a good prognosis and no clear obesity paradox is apparent. Although better 
long-term intervention studies are needed, purposeful weight reduction, and especially 
incorporating exercise training and improvements in fitness, seems to be beneficial. 
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FIGURE LEGENDS 
Figure 1. Pathophysiology of Obesity Cardiomyopathy. This diagram shows the central 
hemodynamic, cardiac structural abnormalities and alterations in ventricular function that may 
occur in severely obese patients and predispose to heart failure. Left ventricular (LV) 
hypertrophy in severe obesity may be eccentric or concentric. In uncomplicated (normotensive) 
severe obesity, eccentric LV hypertrophy predominates. In severely obese patients with long-
standing systemic hypertension, concentric LV hypertrophy is frequently observed and may 
occur more commonly than eccentric LV hypertrophy. Whether and to what extent metabolic 
disturbances such as lipotoxicity, insulin resistance, leptin resistance and alterations of the renin-
angiotensin-aldosterone system contribute to obesity cardiomyopathy in humans is uncertain. RV 
= right ventricular. Adapted with permission from Lavie CJ et al.5 
Figure 2. Occupational METs and energy Expenditure Since 1960. The upper panel plots the 
mean occupation-related METs since 1960 and the lower panel presents the mean occupational 
daily energy expenditure in men and women since 1960. Reproduced with permission from 
Church TS et al.11  
Figure 3. Household Management Energy Expenditure per Week. This figure depicts the decade 
to decade change in Household Management Energy Expenditure per Week (HMEE/week) for 
all women and by employment status. Reproduced with permission from Archer ER et al.12 
Figure 4. Predicted Weights and NHANES Weights. This figure presents the energy balance 
model predicted mean U.S. body weight based on change in occupation related daily energy 
expenditure since 1960 compared to mean U.S. weight gain based on the NHANES examination 
periods for 40-50 year old men (left panel) and women (right panel). Reproduced with 
permission from Church TS et al.11  
Figure 5. Body Composition and CHD Survival. 3-year survival based on body composition: low 
and high body fat (BF) and low and high lean mass index (LMI). Mortality was highest in the 
Low BF/Low LMI group (15% or 9 of 62), followed by the High BF/Low LMI group (5.7% or 3 
of 53), Low BF/High LMI group (4.5% or 8 of 179), and High BF/High LMI group (2.2% or 6 
of 270). BF = body fat; LMI = lean mass index. Reproduced with permission from Lavie CJ et 
al.35 
Figure 6. Obesity Paradox and Fitness in CHD. Joint effects of cardiorespiratory fitness and 
body mass index (BMI) (A), waist circumference (WC) (B), and percent body fat (BF) (C), on 
all-cause mortality. Hazard ratios (boxes) and 95% confidence intervals (error bars represent 
values) after adjusting for age, baseline examination year, physical activity (active or inactive), 
smoking (current smoker or not), alcohol intake (> 14 drinks/wk or not), hypercholesterolemia, 
hypertension and diabetes (present or not for each), and family history of cardiovascular disease. 
Reproduced with permission from McAuley PA et al.34 
Figure 7. Obesity Paradox and Fitness in HF. Kaplan-Meier analyses according to BMI with the 
low CRF group (O2 consumption < 14 mLO2 kg−1 min−1, log rank 11.7, P = .003) and high CRF 
group (O2 consumption ≥ 14 mLO2 kg−1 min−1, log rank 1.72, P = .42) on the left and right, 
respectively. Adapted from data in Lavie CJ et al69 and reproduced with permission from Lavie 
CJ et al.73 
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Table 1.  Effects of Obesity on Cardiac Performance 
 
A.  Hemodynamics 
1.  Increased blood volume 
2.  Increased stroke volume 
3.  Increased arterial pressure 
4.  Increased LV wall stress 
5.  Pulmonary artery hypertension 
B.  Cardiac structure 
1.   LV concentric remodeling 
2.   LV hypertrophy (eccentric and concentric) 
3.   Left atrial enlargement 
4.   RV hypertrophy 
C.  Cardiac function 
1.   LV diastolic dysfunction 
2.   LV systolic dysfunction 
3.   RV failure 
D.  Inflammation 
1.   Increased C-reactive protein 
2.   Overexpression of tumor necrosis factor 
E.  Neurohumoral 
1.   Insulin resistance and hyperinsulinemia 
2.   Leptin insensitivity and hyperleptinemia 
3.   Reduced adiponectin 
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4.   Sympathetic nervous system activation 
5.   Activation of renin-angiotensin-aldosterone system 
6.   Overexpression of peroxisome proliferator-activator receptor 
F.  Cellular 
1.   Hypertrophy 
2.   Apoptosis 
3.   Fibrosis 
 
 
 
 
Abbreviations: LV = left ventricular; RV = right ventricular 
 
Reproduced with permissions from Lavie CJ et al.5 
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Table 2.  Potential Reasons for the Obesity Paradox in Cardiovascular Diseases.   
 
A.  Non-purposeful weight loss 
B.  Younger age at presentation 
C.  Lower prevalence of smoking 
D.  Greater metabolic reserves 
E.  Less cachexia 
F. Lower atrial natriuretic peptides 
G.  Attenuated response to renin-angiotensin-aldosterone system 
H.  High blood pressure, allowing for more cardiac medications 
I.  Differing etiology, associated with a better prognosis 
J.  Increased muscle mass and  muscular strength 
K.  Implications regarding cardiorespiratory fitness 
L. Unmeasured confounding factors 
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